Skip to site menu Skip to page content

A Guide Accross the Regulatory and Scientific Terrain

By Pharmaceutical Development Group

Pharmaceutical Development Group (PDG) is a drug and medical device consultant that continuously engages in meetings and interactions with the US Food and Drug Administration (FDA).

In addition to all types of submission and milestone meetings, the company helps orchestrate the full range of communications such as orphan drug designation requests, requests for designation (drug, device, or biologic), and 513(g) submissions.

As industry experienced regulatory strategists, scientists, and business professionals, PDG is a true project manager, helping you request fast-track or breakthrough designations, managing priority or rolling reviews, and desining study protocols to fit accelerated approvals.

To find out more about PDG's services, including vendor sourcing, life cycle management, labelling, and clinical studies, download this free whitepaper.

Enter your details below to view the free white paper

By downloading this whitepaper, you acknowledge that GlobalData may share your information with our white paper partners/sponsors who may contact you directly with information on their products and services.

Visit our Privacy Policy for more information about our services, how GlobalData may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Related Content